Meet the Team

Joseph Hardie, Ph.D.

Dr. Joseph Hardie is a visionary biomedical engineer and entrepreneur with a passion for bringing cutting‑edge diagnostics to the point of care. As a Postdoctoral Research Fellow at Harvard-affiliated Brigham & Women’s Hospital, he led pioneering work in AI‑enabled, smartphone‑integrated microfluidics for rapid pathogen and biomarker detection.

His scholarly contributions are extensive and impactful with publications in journals such as Nature Biomedical Engineering (2025) and Science Advances article (2025) that introduce novel diagnostic devices for detection of infectious diseases and environmental contaminants.

Joseph’s work bridges laboratory innovation and real-world deployment, his vision for VISTA is built on years of creating ultra-sensitive, miniaturized diagnostic tools designed to work anywhere, from rural clinics to home taps.

He earned his Ph.D. in Chemistry through rigorous, interdisciplinary research focused on nanoparticle therapeutics, immunomodulation, and biosensor development. Early in his career, he helped develop siRNA-based chemotherapeutics and nanoparticle immunotherapies, honing a skill set that combines molecular science with practical engineering.

As founder, Joseph leads with unwavering dedication to health equity, environmental safety, and scientific innovation that doesn’t stay on the shelf. At Effervescence DX, he’s turning his breakthrough research into a global diagnostic infrastructure, because at the point of care, the point is you. (LinkedIn)

Danielle Hardie, HTL(ASCP)

Danielle Hardie, B.S. in Biochemistry & Molecular Biology and HTL(ASCP) certified, is a core member of Effervescence DX. With a strong foundation in molecular biology and histotechnology, Danielle supports the company’s early-stage growth by securing grant funding, cultivating partnerships, and advising on scientific and regulatory strategy.

At this stage of development, roles are fluid, and Danielle thrives in that flexibility. Whether it’s contributing technical expertise, helping structure operational plans, or connecting with key stakeholders, she’s focused on doing what it takes to bring VISTA, Effervescence’s flagship diagnostic platform, to market.

Rooted in a career that blends bench science with community service, Danielle brings both rigor and heart to her work. She’s passionate about expanding access to diagnostics that are intuitive, effective, and designed with real-world users in mind. (LinkedIn)

Danielle Hardie, HTL(ASCP)

Danielle Hardie, B.S. in Biochemistry & Molecular Biology and HTL(ASCP) certified, is a core member of Effervescence DX. With a strong foundation in molecular biology and histotechnology, Danielle supports the company’s early-stage growth by securing grant funding, cultivating partnerships, and advising on scientific and regulatory strategy.

At this stage of development, roles are fluid, and Danielle thrives in that flexibility. Whether it’s contributing technical expertise, helping structure operational plans, or connecting with key stakeholders, she’s focused on doing what it takes to bring VISTA, Effervescence’s flagship diagnostic platform, to market.

Rooted in a career that blends bench science with community service, Danielle brings both rigor and heart to her work. She’s passionate about expanding access to diagnostics that are intuitive, effective, and designed with real-world users in mind. (LinkedIn)